Sitagliptin forhindrer DPP- 4s hydrolyse af inkretinhormoner, og øger dermed plasmakoncentrationerne af de aktive former af GLP- 1 og GIP.
Sitagliptin prevents the hydrolysis of incretin hormones by DPP-4, thereby increasing plasma concentrations of the active forms of GLP-1 and GIP.